April 28, 2005 — Hyperbaric oxygen (HBO 2) therapy given within six months of hematuria onset is effective for radiation-induced hemorrhagic cystitis, according to the results of a retrospective study ...

PITTSBURGH--(BUSINESS WIRE)--Lipella Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on improving cancer survivorship, today announced it has begun recruiting patients in the ...

(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug ...

Please provide your email address to receive an email when new articles are posted on . BK virus-specific cytotoxic T lymphocytes from healthy donors appeared safe and effective for patients with BK ...

Medical researchers have turned the tables on Schistosoma haematobium, a parasitic worm that freeloads in humans, by using a protein derived from the parasite as a therapeutic molecule to reduce ...

Posoleucel is being investigated for the treatment and prevention of serious diseases caused by 6 viral pathogens. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Background. BK virus-associated hemorrhagic cystitis (BKV-HC) is a severe complication after allogeneic hematopoietic stem cell transplantation (HSCT), but antiviral treatment for this condition has ...

"Hemorrhagic Cystitis Market Insight, Epidemiology and Market Forecast report"DelveInsight's comprehensive analysis reveals robust market expansion driven by growing patient population, emerging ...

(MENAFN- GetNews) The Key Hemorrhagic Cystitis Companies in the market include - GSK, AlloVir, Lipella Pharmaceuticals, Novo Nordisk A/S, and others. DelveInsight's “Hemorrhagic Cystitis Market ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...